465 related articles for article (PubMed ID: 26149442)
21. Detection of HER2 amplification in formalin-fixed paraffin-embedded breast carcinoma tissue with digital PCR using two TFF3 sequences as internal reference.
Yu R; Xuan W; Zhou L; Luo Y; Liu X; Xiong P; Ren X
Exp Mol Pathol; 2018 Jun; 104(3):235-238. PubMed ID: 29715436
[TBL] [Abstract][Full Text] [Related]
22. Droplet Digital™ PCR quantitation of HER2 expression in FFPE breast cancer samples.
Heredia NJ; Belgrader P; Wang S; Koehler R; Regan J; Cosman AM; Saxonov S; Hindson B; Tanner SC; Brown AS; Karlin-Neumann G
Methods; 2013 Jan; 59(1):S20-3. PubMed ID: 23036330
[TBL] [Abstract][Full Text] [Related]
23. Human epidermal growth factor receptor 2 amplification detection by droplet digital polymerase chain reaction in formalin-fixed paraffin-embedded breast and gastric cancer samples.
Wang X; Wu Y; Song X; Sun C; Wu C; Feng H
J Cancer Res Ther; 2017; 13(4):730-734. PubMed ID: 28901323
[TBL] [Abstract][Full Text] [Related]
24. Multiple protein analysis of formalin-fixed and paraffin-embedded tissue samples with reverse phase protein arrays.
Assadi M; Lamerz J; Jarutat T; Farfsing A; Paul H; Gierke B; Breitinger E; Templin MF; Essioux L; Arbogast S; Venturi M; Pawlak M; Langen H; Schindler T
Mol Cell Proteomics; 2013 Sep; 12(9):2615-22. PubMed ID: 23653450
[TBL] [Abstract][Full Text] [Related]
25. Profiling signalling pathways in formalin-fixed and paraffin-embedded breast cancer tissues reveals cross-talk between EGFR, HER2, HER3 and uPAR.
Berg D; Wolff C; Malinowsky K; Tran K; Walch A; Bronger H; Schuster T; Höfler H; Becker KF
J Cell Physiol; 2012 Jan; 227(1):204-12. PubMed ID: 21391216
[TBL] [Abstract][Full Text] [Related]
26. A novel proximity assay for the detection of proteins and protein complexes: quantitation of HER1 and HER2 total protein expression and homodimerization in formalin-fixed, paraffin-embedded cell lines and breast cancer tissue.
Shi Y; Huang W; Tan Y; Jin X; Dua R; Penuel E; Mukherjee A; Sperinde J; Pannu H; Chenna A; DeFazio-Eli L; Pidaparthi S; Badal Y; Wallweber G; Chen L; Williams S; Tahir H; Larson J; Goodman L; Whitcomb J; Petropoulos C; Winslow J
Diagn Mol Pathol; 2009 Mar; 18(1):11-21. PubMed ID: 19214113
[TBL] [Abstract][Full Text] [Related]
27. [Availability of fine needle aspirates for the assessment of HER2 gene amplification in invasive breast cancer patients].
Lee JW; Noh WC; Kim MS; Kim HA; Chang YH; Hong YJ; Hong SI; Lee JK
Korean J Lab Med; 2008 Oct; 28(5):392-9. PubMed ID: 18971621
[TBL] [Abstract][Full Text] [Related]
28. Antipeptide Immunocapture with In-Sample Calibration Curve Strategy for Sensitive and Robust LC-MS/MS Bioanalysis of Clinical Protein Biomarkers in Formalin-Fixed Paraffin-Embedded Tumor Tissues.
Zheng N; Taylor K; Gu H; Santockyte R; Wang XT; McCarty J; Adelakun O; Zhang YJ; Pillutla R; Zeng J
Anal Chem; 2020 Nov; 92(21):14713-14722. PubMed ID: 33047598
[TBL] [Abstract][Full Text] [Related]
29. Applications of mass spectrometry for quantitative protein analysis in formalin-fixed paraffin-embedded tissues.
Steiner C; Ducret A; Tille JC; Thomas M; McKee TA; Rubbia-Brandt L; Scherl A; Lescuyer P; Cutler P
Proteomics; 2014 Mar; 14(4-5):441-51. PubMed ID: 24339433
[TBL] [Abstract][Full Text] [Related]
30. Technical validation of an RT-qPCR in vitro diagnostic test system for the determination of breast cancer molecular subtypes by quantification of ERBB2, ESR1, PGR and MKI67 mRNA levels from formalin-fixed paraffin-embedded breast tumor specimens.
Laible M; Schlombs K; Kaiser K; Veltrup E; Herlein S; Lakis S; Stöhr R; Eidt S; Hartmann A; Wirtz RM; Sahin U
BMC Cancer; 2016 Jul; 16():398. PubMed ID: 27389414
[TBL] [Abstract][Full Text] [Related]
31. Multiplexed tandem polymerase chain reaction identifies strong expression of oestrogen receptor and Her-2 from single, formalin-fixed, paraffin-embedded breast cancer sections.
Thompson EW; Warton K; Blick T; Wafai R; Hill P; Stanley K
Pathology; 2010 Feb; 42(2):165-72. PubMed ID: 20085519
[TBL] [Abstract][Full Text] [Related]
32. Simultaneous detection of HER2/neu gene amplification and protein overexpression in paraffin-embedded breast cancer.
Lottner C; Schwarz S; Diermeier S; Hartmann A; Knuechel R; Hofstaedter F; Brockhoff G
J Pathol; 2005 Apr; 205(5):577-84. PubMed ID: 15732132
[TBL] [Abstract][Full Text] [Related]
33. Parallel Reaction Monitoring-Mass Spectrometry (PRM-MS)-Based Targeted Proteomic Surrogates for Intrinsic Subtypes in Breast Cancer: Comparative Analysis with Immunohistochemical Phenotypes.
Park J; Oh HJ; Han D; Wang JI; Park IA; Ryu HS; Kim Y
J Proteome Res; 2020 Jul; 19(7):2643-2653. PubMed ID: 31755719
[TBL] [Abstract][Full Text] [Related]
34. Quantitative determination of estrogen receptor, progesterone receptor, and HER2 mRNA in formalin-fixed paraffin-embedded tissue--a new option for predictive biomarker assessment in breast cancer.
Müller BM; Kronenwett R; Hennig G; Euting H; Weber K; Bohmann K; Weichert W; Altmann G; Roth C; Winzer KJ; Kristiansen G; Petry C; Dietel M; Denkert C
Diagn Mol Pathol; 2011 Mar; 20(1):1-10. PubMed ID: 21326033
[TBL] [Abstract][Full Text] [Related]
35. Fresh Frozen Versus Formalin-Fixed Paraffin Embedded for Mass Spectrometry Imaging.
Patel E
Methods Mol Biol; 2017; 1618():7-14. PubMed ID: 28523495
[TBL] [Abstract][Full Text] [Related]
36. Genome-wide gene expression profiling of formalin-fixed paraffin-embedded breast cancer core biopsies using microarrays.
Budczies J; Weichert W; Noske A; Müller BM; Weller C; Wittenberger T; Hofmann HP; Dietel M; Denkert C; Gekeler V
J Histochem Cytochem; 2011 Feb; 59(2):146-57. PubMed ID: 21339180
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of HER2 Gene Status in Breast Cancer Samples with Indeterminate Fluorescence in Situ Hybridization by Quantitative Real-Time PCR.
Koudelakova V; Berkovcova J; Trojanec R; Vrbkova J; Radova L; Ehrmann J; Kolar Z; Melichar B; Hajduch M
J Mol Diagn; 2015 Jul; 17(4):446-55. PubMed ID: 25956448
[TBL] [Abstract][Full Text] [Related]
38. Histological assessment of PAXgene tissue fixation and stabilization reagents.
Kap M; Smedts F; Oosterhuis W; Winther R; Christensen N; Reischauer B; Viertler C; Groelz D; Becker KF; Zatloukal K; Langer R; Slotta-Huspenina J; Bodo K; de Jong B; Oelmuller U; Riegman P
PLoS One; 2011; 6(11):e27704. PubMed ID: 22110732
[TBL] [Abstract][Full Text] [Related]
39. Human epidermal growth factor receptor 2 testing in gastroesophageal cancer: correlation between immunohistochemistry and fluorescence in situ hybridization.
Tafe LJ; Janjigian YY; Zaidinski M; Hedvat CV; Hameed MR; Tang LH; Hicks JB; Shah MA; Barbashina V
Arch Pathol Lab Med; 2011 Nov; 135(11):1460-5. PubMed ID: 22032573
[TBL] [Abstract][Full Text] [Related]
40. Reference Size Matching, Whole-Genome Amplification, and Fluorescent Labeling as a Method for Chromosomal Microarray Analysis of Clinically Actionable Copy Number Alterations in Formalin-Fixed, Paraffin-Embedded Tumor Tissue.
Gunn SR; Govender S; Sims CL; Khurana A; Koo S; Scoggin J; Moore MW; Cotter PD
J Mol Diagn; 2018 May; 20(3):279-288. PubMed ID: 29471114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
